- Ana Sayfa
- Uygulama Analitiği
- Shared Investigator Platform
- Shared Investigator Platform Vs. Teckro
Shared Investigator Platform vs Teckro Kullanım & İstatistikleri
The Shared Investigator Platform (Cognizant SIP) Mobile App features a user friendly interface to navigate and manage your actions on the Shared Investigator Platform. With this app, site users can easily login using their existing SIP credentials and enable biometric authentication to simplify the subsequent login process. This app offers an easy review of the pending actions, accept study & pre-study invitations, Complete facility association tasks, view the study news, view study documents, complete Document Exchange tasks published by your sponsor organizations.
- Apple App Store
- BOŞTA
- Medikal
Mağaza Sıralaması
- -
Teckro transforms your clinical trial protocol into a hub of communication and collaboration. It’s a digital platform that connects all study stakeholders with the knowledge they need, when they need it. Drugs from trials powered by Teckro have been granted priority review and approval by regulators in the US and Europe. Thousands of investigators and 20,000+ sites around the world rely on Teckro to execute clinical trials from biopharma sponsors, including 12 out of the Top 20 pharma companies. We support all therapeutic areas, all phases, and any trial model, whether traditional, virtual, or a hybrid approach - if Teckro isn't used on your clinical trial, ask your study manager for it.
- Apple App Store
- BOŞTA
- Medikal
Mağaza Sıralaması
- -
Shared Investigator Platform ile Teckro için sıralama karşılaştırması
Son 28 gündeki Shared Investigator Platform sıralama trendini Teckroile karşılaştırın
Rank
Mevcut veri yok
Shared Investigator Platform vs. Teckro ülke karşılaştırmasına göre sıralama
Son 28 gündeki Shared Investigator Platform sıralama trendini Teckroile karşılaştırın
Tüm kategoriler
Mevcut veri yok
Medikal
Ücretsiz deneme sürümümüzü kullanarak istediğiniz siteyle karşılaştırın
Shared Investigator Platform VS.
Teckro
Aralık 17, 2024